Patents by Inventor Alshad Lalani

Alshad Lalani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
    Publication number: 20080069814
    Abstract: The present invention relates to a method for preventing, treating, or ameliorating thrombotic disorders in an animal comprising administering to the animal an active vitamin D compound or a mimic thereof. According to the invention, the active vitamin D compound or the mimic thereof may be administered by HDPA so that high doses of the active vitamin D compound or the mimic thereof can be administered to an animal without inducing severe symptomatic hypercalcemia. The invention also relates a method for preventing, treating, or ameliorating thrombotic disorders in an animal comprising administering to the animal an active vitamin D compound or a mimic thereof in combination with one or more other therapeutic agents.
    Type: Application
    Filed: March 26, 2007
    Publication date: March 20, 2008
    Inventors: John CURD, William HENNER, Tomasz BEER, Bradford GOODWIN, Alshad LALANI
  • Treatment of hyperproliferative diseases with anthraquinones
    Publication number: 20070117784
    Abstract: The invention relates to anthraquinone compounds having activity for treating hyperproliferative disorders. Further, the invention relates to methods of using the compounds, alone or in combination with one or more other active agents or treatments, to treat hyperproliferative disorders.
    Type: Application
    Filed: September 13, 2006
    Publication date: May 24, 2007
    Inventors: Jeffrey Cleland, Alvin Wong, Alshad Lalani
  • Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
    Patent number: 7186699
    Abstract: The present invention provides therapeutic compositions and methods for vector-mediated delivery and in vivo expression of polynucleotides encoding anti-cancer compounds that are effective in the treatment of cancer. In particular, the invention relates to the use of recombinant viral and non-viral vectors to deliver genes encoding one or more anti-angiogenic or proapoptotic gene products for the treatment of cancer.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: March 6, 2007
    Assignee: Cell Genesys, Inc.
    Inventors: Thomas Harding, Karin Jooss, Alshad Lalani, Brian Donahue
  • Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
    Publication number: 20050031593
    Abstract: The present invention provides therapeutic compositions and methods for vector-mediated delivery and in vivo expression of polynucleotides encoding anti-cancer compounds that are effective in the treatment of cancer. In particular, the invention relates to the use of recombinant viral and non-viral vectors to deliver genes encoding one or more anti-angiogenic or proapoptotic gene products for the treatment of cancer.
    Type: Application
    Filed: May 28, 2004
    Publication date: February 10, 2005
    Inventors: Thomas Harding, Karin Jooss, Alshad Lalani, Brian Donahue